07:48 AM EDT, 09/17/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday its phase 3 study of garetosmab in adults with fibrodysplasia ossificans progressiva, or FOP, met its primary endpoint, demonstrating a greater reduction in new bone lesions compared with placebo. The company said the trial enrolled 63 people with FOP aged at least 18 years old. The...

07:50 AM EDT, 09/17/2025 (MT Newswires) -- Life sciences company Microbix Biosystems ( MBXBF ) and Finnish company Labquality on Wednesday announced an external quality assessment (EQA) program to help clinical laboratories accurately identify head and neck cancers (HNC) associated with cancer-causing strains of the human papilloma virus (HPV). A pilot EQA study was conducted earlier this year involving 32...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

07:48 AM EDT, 09/17/2025 (MT Newswires) -- Canopy Growth Corporation ( CGC ) said Wednesday that Tom Stewart has been appointed chief financial officer, effective immediately. He has worked as interim CFO since July and has been part of Canopy Growth's ( CGC ) senior finance team since 2019, contributing to initiatives like debt repayments and capital raising, the company...